[1]王 婧,秦燕鸿,刘 刚,等.芪贝消痈汤治疗幽门螺杆菌阳性胃溃疡临床研究[J].陕西中医,2024,(2):217-221.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.015]
　WANG Jing,QIN Yanhong,LIU Gang,et al.Clinical study of Qibei Xiaoyong decoction in treating helicobacter pylori-positive gastric ulcer[J].,2024,(2):217-221.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.015]
点击复制

芪贝消痈汤治疗幽门螺杆菌阳性胃溃疡临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年2期
页码:
217-221
栏目:
临床研究
出版日期:
2024-02-05

文章信息/Info

Title:
Clinical study of Qibei Xiaoyong decoction in treating helicobacter pylori-positive gastric ulcer
作者:
王 婧; 秦燕鸿; 刘 刚; 李国霞
(河北省沧州中西医结合医院,河北 沧州 062650)
Author(s):
WANG Jing; QIN Yanhong; LIU Gang; LI Guoxia
(Cangzhou Hospital of Integrative Medicine,Cangzhou 062650,China)
关键词:
HP阳性胃溃疡;  芪贝消痈汤;  氧化应激反应;  NF-κB信号通路;  炎性反应;  溃疡修复
Keywords:
HP-positive gastric ulcer;  Qibei Xiaoyong decoction;  Oxidative stress response;  NF-κB signaling pathway;  Inflammatory response;  Ulcer repair
分类号:
R 256.3
DOI:
DOI:10.3969/j.issn.1000-7369.2024.02.015
文献标志码:
A
摘要:
目的:基于氧化应激反应、核因子κB(NF-κB)信号通路探讨芪贝消痈汤治疗幽门螺杆菌(HP)阳性胃溃疡的效果观察。方法:选取HP阳性胃溃疡患者96例为研究对象,按照随机数字表法分为对照组和观察组,各48例。对照组采用西医药物治疗,观察组在对照组基础联合芪贝消痈汤治疗。比较两组治疗4周后临床疗效,治疗前及治疗4周后中医症候积分、胃镜检查指标(溃疡直径、底部厚苔面积、溃疡周围黏膜充血面积及再生上皮面积)、氧化应激指标[超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮(NO)]、炎性反应指标[肿瘤坏死因子-α(TNF-α)、白细胞介素8(IL-8)、基质金属蛋白酶9(MMP-9)、基质金属蛋白酶抑制剂1(TIMP-1)]、NF-κB阳性表达率,比较治疗后1个月HP根除率及12个月内复发情况。结果:治疗4周后,观察组临床疗效为93.75%,高于对照组的79.17%(P<0.05); 治疗4周后,两组胃脘胀痛、恶心呕吐、嗳气反酸、胃脘灼烧感症候积分、溃疡直径、底部厚苔面积及周围黏膜充血面积、血清MDA、TNF-α、IL-8、MMP-9、TIMP-1水平较治疗前降低,且观察组低于对照组(P<0.05); 两组再生上皮面积、血清SOD及NO水平较治疗前升高,且观察组高于对照组(P<0.05); 治疗4周后观察组NF-κB阳性表达率为22.92%,低于对照组的43.75%(P<0.05)。治疗后1个月观察组HP根除率为93.75%,高于对照组的70.83%(P<0.05)。治疗后12个月内观察组复发率为6.25%,低于对照组的20.83%(P<0.05)。结论:芪贝消痈汤能通过减弱氧化应激反应、抑制NF-κB信号通路表达,改善HP阳性胃溃疡患者临床症状,缓解胃的炎性反应,进而促进溃疡修复,减少复发风险。
Abstract:
Objective:To observe the effect of Qibei Xiaoyong decoction in the treatment of helicobacter pylori(HP)-positive gastric ulcer based on oxidative stress response and nuclear factor κB(NF-κB)signaling pathway.Methods:A total of 96 patients with HP-positive gastric ulcer were selected as the research subjects,and were divided into control group and observation group according to the random number table method,with 48 cases in each group.The control group was treated with western medicine,and the observation group was given Qibei Xiaoyong decoction on the basis of the control group.The clinical efficacy after 4 weeks of treatment,TCM syndromes scores,gastroscopy indicators(ulcer diameter,bottom thick moss area,mucosal congestion area around ulcer and regenerated epithelial area),oxidative stress indicators [superoxide dismutase(SOD),malondialdehyde(MDA),nitric oxide(NO)],inflammatory response indicators [tumor necrosis factor-α(TNF-α),interleukin-8(IL-8),matrix metalloproteinase-9(MMP-9),tissue inhibitor of metalloproteinase-1(TIMP-1)] and positive expression rate of NF-κB before treatment and after 4 weeks of treatment and HP eradication rate at 1 month after treatment and recurrence within 12 months were compared.Results:After 4 weeks of treatment,the clinical efficacy in observation group was 93.75%,which was higher than 79.17% in control group(P<0.05).The scores of syndromes such as epigastric distension pain,nausea and vomiting,belching and acid regurgitation and epigastric burning sensation,ulcer diameter,bottom thick moss area and surrounding mucosal congestion area and levels of serum MDA,TNF-α,IL-8,MMP-9 and TIMP-1 in both groups after 4 weeks of treatment were reduced compared with those before treatment,and the above indicators in observation group were lower than those in control group(P<0.05).The regenerated epithelial area and levels of serum SOD and NO in both groups were enhanced compared to before treatment,and the indicators in observation group were higher than those in control group(P<0.05).The positive expression rate of NF-κB in observation group was 22.92% after 4 weeks of treatment,which was lower than 43.75% in control group(P<0.05).The eradication rate of HP with 93.75% in observation group at 1 month after treatment was higher than 70.83% in control group(P<0.05),and the recurrence rate with 6.25% within 12 months after treatment was lower than 20.83% in control group(P<0.05).Conclusion:Qibei Xiaoyong decoction can reduce the oxidative stress response,inhibit the expression of NF-κB signaling pathway,improve the clinical symptoms of patients with HP-positive gastric ulcer,relieve the gastritis reaction,promote the ulcer repair,and reduce the risk of recurrence.

参考文献/References:

[1] 刘伟平,隆霞.幽门螺杆菌抗体分型及胃蛋白酶原联合检测在上消化道良性疾病诊断中的临床意义[J].成都医学院学报,2021,16(2):173-175,179.
[2] 冯正平,梁杏花,刘佛球.2191例消化性溃疡的胃镜和流行病学分析[J].重庆医学,2020,49(7):1114-1117.
[3] 杨柳青,陈建婷.以埃索美拉唑为核心的四联疗法根除幽门螺杆菌35例临床观察[J].陕西医学杂志,2011,40(7):918-918.
[4] 魏桂双.中药黄芪建中汤与常规西医治疗胃溃疡临床疗效比较[J].现代中西医结合杂志,2014,23(14):1524-1525.
[5] 程刚.黄芪建中汤治疗幽门螺旋杆菌阳性胃溃疡32例[J].陕西中医,2013,34(1):20-21.
[6] 中国中西医结合学会消化系统疾病专业委员会.消化性溃疡中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):112-120.
[7] 中华人民共和国卫生部.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:151-155.
[8] TAKEMOTO T,SASAKI N,TADA M,et al.Evaluation of peptic ulcer healing with a highly magnifying endoscope:Potential prognostic and therapeutic implications[J].J Clin Gastroenterol,1991,13(11):125-128.
[9] 马艳,毛志田.香砂六君子汤联合西药治疗HP阳性脾胃虚弱型消化性溃疡临床研究[J].陕西中医,2020,41(3):357-359.
[10] 孙雪莲,黄可儿,匡忠生,等.黄芪皂苷类不同有效组分对大鼠急性胃黏膜损伤的保护作用研究[J].中华中医药杂志,2011,26(5):1181-1185.
[11] 李备,刘华蓉,潘永全,等.黄连总生物碱对乙醇致大鼠胃黏膜损伤的保护作用及其机制探讨[J].中国中药杂志,2006,31(1):51-54.
[12] 于英莉.黄连温胆汤治疗脾胃湿热型HP阳性浅表性胃炎及对SOD和NO的影响[J].陕西中医,2016,37(11):1449-1451.
[13] 郑冬梅.奥美拉唑、泮托拉唑、兰索拉唑治疗胃溃疡疗效比较[J].现代中西医结合杂志,2014,25(22):2461-2463.
[14] 姚玉龙.泮托拉唑与兰索拉唑治疗胃溃疡的药物经济学分析[J].实用临床医药杂志,2013,17(7):82-84.
[15] 袁浩壬,付晓林.HP感染性胃溃疡患者血清炎症因子、MMP-9和TIMP-1水平变化及其与炎性活动度的相关性[J].海南医学,2022,33(8):968-971.
[16] 楚有良,张沥,陶梅,等.血清IL-6、IL-8在盐水致大鼠萎缩性胃炎发生发展过程中的作用[J].陕西医学杂志,2007,36(7):807-809.
[17] 李向阳,任磊,梁瑞.血清基质金属蛋白酶-9、基质金属蛋白酶-2水平对胃癌腹膜转移及预后的预测价值[J].陕西医学杂志,2023,52(2):166-170.
[18] 张靖宇,张震宇,曾利,等.血清炎性因子对HP感染胃溃疡患者免疫功能的评估效果[J].中华医院感染学杂志,2019,29(22):3419-3422.
[19] 代敏涛,吴太宇,张宇,等.胃炎患者幽门螺杆菌感染与血清学指标及病理的相关性[J].中华医院感染学杂志,2019,29(24):3719-3723.
[20] 张厚,宋延秋,陈广军.黄芪总皂苷对脾虚大鼠胃黏膜损伤的抑制作用和血流量的改善作用研究[J].陕西中医,2017,38(10):1484-1486.
[21] 姚晓艳,刘文,宋信莉,等.黄连抗胃溃疡炎症的活性成分研究[J].中华中医药杂志,2020,35(3):1480-1483.
[22] 赵艳,王万里,李宾,等.幽门螺杆菌感染性胃溃疡患者COX-2、NF-κB p65和MMP-9及TIMP-1水平变化及临床意义[J].热带医学杂志,2021,21(12):1548-1552.
[23] 吕玉玲,谭梅英,廖银标.养胃颗粒中NF-κB靶标介导的治疗胃溃疡成分的筛选与评价研究[J].实用药物与临床,2020,23(3):253-257.
[24] 仇婧玥,陈小娟,曾梅艳,等.黄芪建中汤下调TLR-2、p-NF-κB表达治疗消化性溃疡的效应及机制研究[J].天然产物研究与开发,2023,35(3):477-488.
[25] 巩子汉,段永强,成映霞,等.白及多糖对胃溃疡模型大鼠胃组织IL-17、IL-23、TLR-4及NF-κB p65基因和蛋白表达水平影响的研究[J].中国免疫学杂志,2020,36(7):821-825,836.

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研项目(2020462)
更新日期/Last Update: 2024-02-07